Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study if the addition of the green tea extract, Polyphenon E,
to Erlotinib is safe and if it has potential to improve outcomes in second line therapy for
Advanced Stage IIIb/IV Non-small cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Louisiana State University Health Sciences Center Shreveport